Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Net Margin (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Net Margin data on record, last reported at 362.73% in Q3 2025.

  • For Q3 2025, Net Margin fell 3743.0% year-over-year to 362.73%; the TTM value through Sep 2025 reached 586.1%, down 51093.0%, while the annual FY2024 figure was 62.32%, N/A changed from the prior year.
  • Net Margin reached 362.73% in Q3 2025 per GOSS's latest filing, down from 333.13% in the prior quarter.
  • Across five years, Net Margin topped out at 1698.73% in Q3 2022 and bottomed at 397.03% in Q1 2025.
  • Average Net Margin over 4 years is 698.47%, with a median of 816.25% recorded in 2023.
  • Peak YoY movement for Net Margin: plummeted -152206bps in 2024, then crashed -3743bps in 2025.
  • A 4-year view of Net Margin shows it stood at 1655.19% in 2022, then dropped by -28bps to 1196.77% in 2023, then tumbled by -64bps to 435.74% in 2024, then crashed by -183bps to 362.73% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 362.73% in Q3 2025, 333.13% in Q2 2025, and 397.03% in Q1 2025.